MARKET

VANI

VANI

Vivani Medical
NASDAQ
0.9834
-0.1466
-12.97%
After Hours: 0.9900 +0.0066 +0.67% 19:30 11/12 EST
OPEN
1.120
PREV CLOSE
1.130
HIGH
1.120
LOW
0.8001
VOLUME
1.39M
TURNOVER
--
52 WEEK HIGH
1.661
52 WEEK LOW
0.8001
MARKET CAP
88.71M
P/E (TTM)
-2.7400
1D
5D
1M
3M
1Y
5Y
1D
Vivani Medical Reports Positive Phase 1 Results For Semaglutide Implant NPM-139; Stock Down
NASDAQ · 8h ago
Vivani Medical Advances Long-Acting Semaglutide Implant Toward Phase 2 Trial in 2027
Benzinga · 8h ago
Vivani Medical Reports SLIM-1 Phase 1 Trial Results
TipRanks · 11h ago
Vivani's Q3 Loss Widens Mildly To $7 Mln; Data For GLP-1 Implant Expected Later This Week
NASDAQ · 15h ago
Vivani Medical Q3 EPS $(0.08), Inline
Benzinga · 1d ago
Vivani Medical GAAP EPS of -$0.08 beats by $0.01
Seeking Alpha · 1d ago
*Vivani Medical 3Q Loss/Shr 8c >VANI
Dow Jones · 1d ago
Vivani Medical: Q3 Earnings Snapshot
Barchart · 1d ago
More
About VANI
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its segments include the Biopharm Division and Neurostimulation Division. Its pipeline includes NPM-139, NPM-133, NPM-115 and OKV-119. NPM-139 is a six-month, semaglutide implant under development for the treatment of chronic weight management. NPM-115 is an exenatide-based implant candidate also under development for the treatment of chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed for once or twice-yearly administration of medication.

Webull offers Vivani Medical Inc stock information, including NASDAQ: VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.